Global Bioenergies’ (GBE) acquisition of Syngip in an all-share deal further strengthens the company’s third-generation processes and as such is very synergistic. Our valuation range is now €34-51 per share (from €37-56) due to the higher share count.
08 Mar 2017
Synergistic acquisition for new markets
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Synergistic acquisition for new markets
Global Bioenergies SA (ALGBE:PAR) | 0 0 1.6% | Mkt Cap: 77.3m
- Published:
08 Mar 2017 -
Author:
Catharina Hillenbrand-Saponar -
Pages:
4
Global Bioenergies’ (GBE) acquisition of Syngip in an all-share deal further strengthens the company’s third-generation processes and as such is very synergistic. Our valuation range is now €34-51 per share (from €37-56) due to the higher share count.